Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Wiesenfarth

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Biometrics|August 1, 2019
Quantification of prior impact in terms of effective current sample sizeManuel Wiesenfarth, Silvia Calderazzo
Biometrical Journal. Biometrische Zeitschrift|July 3, 2019
Power gains by using external information in clinical trials are typically not possible when requiring strict type I error controlAnnette Kopp-Schneider, Silvia Calderazzo, Manuel Wiesenfarth
Biostatistics (Oxford, England)|August 1, 2020
A decision-theoretic approach to Bayesian clinical trial design and evaluation of robustness to prior-data conflictSilvia Calderazzo, Manuel Wiesenfarth, Annette Kopp-Schneider
Biometrical Journal. Biometrische Zeitschrift|December 8, 2023
Robust incorporation of historical information with known type I error rate inflationSilvia Calderazzo, Manuel Wiesenfarth, Annette Kopp-Schneider
Journal of Biopharmaceutical Statistics|December 28, 2021
On the feasibility of pediatric dose-finding trials in small samples with information from a preceding trial in adultsDario Zocholl, Manuel Wiesenfarth, Geraldine Rauch, et al.
Pharmaceutical Statistics|August 26, 2023
Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trialsAnnette Kopp-Schneider, Manuel Wiesenfarth, Leonhard Held, et al.
European Urology|August 28, 2020
Re: The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical ProstatectomyJan Philipp Radtke, Joanne Nyarangi-Dix, Manuel Wiesenfarth, et al.
Biometrical Journal. Biometrische Zeitschrift|September 4, 2018
Monitoring futility and efficacy in phase II trials with Bayesian posterior distributions-A calibration approachAnnette Kopp-Schneider, Manuel Wiesenfarth, Ruth Witt, et al.
Immunity & Ageing : I & A|April 3, 2024
Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer's disease and vascular dementia in a prospective studyKira Trares, Manuel Wiesenfarth, Hannah Stocker, et al.
Scientific Reports|January 28, 2021
Methods and open-source toolkit for analyzing and visualizing challenge resultsManuel Wiesenfarth, Annika Reinke, Bennett A Landman, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Biometrics|August 1, 2019
Quantification of prior impact in terms of effective current sample sizeManuel Wiesenfarth, Silvia Calderazzo
Biometrical Journal. Biometrische Zeitschrift|July 3, 2019
Power gains by using external information in clinical trials are typically not possible when requiring strict type I error controlAnnette Kopp-Schneider, Silvia Calderazzo, Manuel Wiesenfarth
Biostatistics (Oxford, England)|August 1, 2020
A decision-theoretic approach to Bayesian clinical trial design and evaluation of robustness to prior-data conflictSilvia Calderazzo, Manuel Wiesenfarth, Annette Kopp-Schneider
Biometrical Journal. Biometrische Zeitschrift|December 8, 2023
Robust incorporation of historical information with known type I error rate inflationSilvia Calderazzo, Manuel Wiesenfarth, Annette Kopp-Schneider
Journal of Biopharmaceutical Statistics|December 28, 2021
On the feasibility of pediatric dose-finding trials in small samples with information from a preceding trial in adultsDario Zocholl, Manuel Wiesenfarth, Geraldine Rauch, et al.
Pharmaceutical Statistics|August 26, 2023
Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trialsAnnette Kopp-Schneider, Manuel Wiesenfarth, Leonhard Held, et al.
European Urology|August 28, 2020
Re: The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical ProstatectomyJan Philipp Radtke, Joanne Nyarangi-Dix, Manuel Wiesenfarth, et al.
Biometrical Journal. Biometrische Zeitschrift|September 4, 2018
Monitoring futility and efficacy in phase II trials with Bayesian posterior distributions-A calibration approachAnnette Kopp-Schneider, Manuel Wiesenfarth, Ruth Witt, et al.
Immunity & Ageing : I & A|April 3, 2024
Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer's disease and vascular dementia in a prospective studyKira Trares, Manuel Wiesenfarth, Hannah Stocker, et al.
Scientific Reports|January 28, 2021
Methods and open-source toolkit for analyzing and visualizing challenge resultsManuel Wiesenfarth, Annika Reinke, Bennett A Landman, et al.
Pageof 5